Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.

about

Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.

Item

http://www.wikidata.org/entity/Q38783065

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Anti-thyroglobulin antibodies ...... -risk thyroid cancer patients.

@en

type

Item

label

Anti-thyroglobulin antibodies ...... -risk thyroid cancer patients.

@en

prefLabel

Anti-thyroglobulin antibodies ...... -risk thyroid cancer patients.

@en

P1476

Anti-thyroglobulin antibodies ...... w-risk thyroid cancer patients

@en

P2093

F Nabhan

http://www.w3.org/2001/XMLSchema#string

L Senter

http://www.w3.org/2001/XMLSchema#string

M D Ringel

http://www.w3.org/2001/XMLSchema#string

P2860

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature.

Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.

Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.

P2888

s40618-017-0685-z

P304

1015-1021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-017-0685-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kyle Porter

P577

2017-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085419979

http://www.w3.org/2001/XMLSchema#string

P698

28510122

http://www.w3.org/2001/XMLSchema#string